Winton Group LTD Novavax Inc Transaction History

Winton Group LTD

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 28, 2021	SELL	$177.8 - $270.58 $317,195 - $482,714	-1,784 Closed	0 $0
Q2 2021 Aug 10, 2021	SELL	$121.0 - $257.67 $46,101 - $98,172	-381 Reduced 17.6%	1,784 $379,000
Q1 2021 Jul 21, 2021	BUY	$112.98 - $319.93 $244,601 - $692,648	2,165 New	2,165 $393,000
Q4 2020 Feb 12, 2021	SELL	$78.74 - $139.5 $649,762 - $1.15 Million	-8,252 Closed	0 $0
Q3 2020 Oct 30, 2020	BUY	$79.44 - $178.51 $655,538 - $1.47 Million	8,252 New	8,252 $894,000
Q4 2019 Feb 13, 2020	SELL	$3.69 - $5.22 $281,912 - $398,802	-76,399 Closed	0 $0
Q3 2019 Nov 08, 2019	BUY	$4.02 - $7.84 $307,123 - $598,968	76,399 New	76,399 $384,000

284

84.8M

5.43M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $731M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Winton Group LTD, based on Form 13F filings with the SEC.

Stay updated on Winton Group LTD with notifications on news.